As the Australian share market edges towards a soft upswing, buoyed by global political developments and commodity price movements, investors are keenly observing potential opportunities. Penny stocks, though often seen as a term from past market eras, continue to hold relevance for those looking to explore beyond established names. These smaller or newer companies can offer affordability and growth potential when backed by robust financials; in this article, we highlight three such penny stocks that stand out for their financial resilience and promising prospects.
Top 10 Penny Stocks In Australia
| Name | Share Price | Market Cap | Rewards & Risks |
| Alfabs Australia (ASX:AAL) | A$0.475 | A$136.13M | ✅ 4 ⚠️ 3 View Analysis > |
| Dusk Group (ASX:DSK) | A$0.90 | A$56.04M | ✅ 4 ⚠️ 2 View Analysis > |
| IVE Group (ASX:IGL) | A$2.76 | A$424.49M | ✅ 4 ⚠️ 3 View Analysis > |
| MotorCycle Holdings (ASX:MTO) | A$3.42 | A$252.42M | ✅ 4 ⚠️ 2 View Analysis > |
| Pureprofile (ASX:PPL) | A$0.043 | A$50.3M | ✅ 3 ⚠️ 1 View Analysis > |
| West African Resources (ASX:WAF) | A$3.04 | A$3.47B | ✅ 4 ⚠️ 1 View Analysis > |
| LaserBond (ASX:LBL) | A$0.505 | A$59.63M | ✅ 4 ⚠️ 1 View Analysis > |
| Fleetwood (ASX:FWD) | A$3.17 | A$292.7M | ✅ 3 ⚠️ 2 View Analysis > |
| GWA Group (ASX:GWA) | A$2.48 | A$652.07M | ✅ 4 ⚠️ 1 View Analysis > |
| Clover (ASX:CLV) | A$0.625 | A$104.37M | ✅ 3 ⚠️ 2 View Analysis > |
Click here to see the full list of 419 stocks from our ASX Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Alfabs Australia (ASX:AAL)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Alfabs Australia Limited operates in the mining equipment and engineering sector within Australia, with a market cap of A$136.13 million.
Operations: The company generates revenue through its Mining segment, which contributes A$45.40 million, and its Engineering segment, which accounts for A$46.34 million.
Market Cap: A$136.13M
Alfabs Australia Limited, with a market cap of A$136.13 million, operates in the mining equipment and engineering sector. It reported sales of A$95.5 million for the year ending June 30, 2025, with net income rising to A$12.17 million from A$3.55 million the previous year. Although its Return on Equity is low at 18.8%, earnings grew by a very large margin over the past year compared to industry averages and are forecasted to grow further by 12.23% annually. The company's debt is well covered by operating cash flow, but its dividend sustainability remains questionable due to insufficient free cash flows.
- Click to explore a detailed breakdown of our findings in Alfabs Australia's financial health report.
- Explore Alfabs Australia's analyst forecasts in our growth report.
Bubs Australia (ASX:BUB)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Bubs Australia Limited, with a market cap of A$138.59 million, manufactures and sells infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally.
Operations: The company generates revenue primarily from its food processing segment, amounting to A$102.54 million.
Market Cap: A$138.59M
Bubs Australia, with a market cap of A$138.59 million, has recently transitioned to profitability, reporting A$5.54 million in net income for the year ending June 30, 2025. Despite low Return on Equity at 13.1%, its revenue reached A$102.54 million, marking significant growth from the previous year. The company is debt-free and has stable weekly volatility at 9%. However, concerns about its long-term viability have been raised by auditors expressing doubts over its going concern status. Recent leadership changes include the appointment of Joe Coote as CEO and Ms Olga Smejkalova as Company Secretary.
- Take a closer look at Bubs Australia's potential here in our financial health report.
- Understand Bubs Australia's earnings outlook by examining our growth report.
Parkway (ASX:PWN)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Parkway Corporate Limited, with a market cap of A$35.97 million, provides water treatment products and solutions in Australia.
Operations: The company generates revenue of A$15.12 million from its water treatment related products and services segment.
Market Cap: A$35.97M
Parkway Corporate Limited, with a market cap of A$35.97 million, has shown promising growth by becoming profitable this year, reporting sales of A$15.14 million for the full year ending June 30, 2025. The company holds more cash than debt and its operating cash flow comfortably covers its liabilities. While Parkway's Return on Equity remains low at 0.1%, it has secured contracts worth over A$13.50 million in water infrastructure projects, expecting additional revenue recognition in fiscal year 2026 despite potential delays in project timelines. The board and management are experienced with stable weekly volatility at 13%.
- Unlock comprehensive insights into our analysis of Parkway stock in this financial health report.
- Review our historical performance report to gain insights into Parkway's track record.
Where To Now?
- Dive into all 419 of the ASX Penny Stocks we have identified here.
- Searching for a Fresh Perspective? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 37 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Bubs Australia might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com